The first healthy volunteers have been dosed in a Phase 1 clinical trial testing a combination therapy for metabolic dysfunction-associated…
Articles by Marisa Wexler, MS
A three-year program in Oregon is receiving a $7.5-million federal grant to improve healthcare for rural residents who use recreational…
The American Liver Foundation (ALF) is launching a first-of-its kind national database, called the ALF Living Donor Network,…
A combination of pemafibrate and telmisartan, two medications approved in some countries to help manage cardiovascular conditions, may help reduce…
Enrollment is complete in two Phase 2 clinical trials testing Ausperbio’s AHB-137 in people with chronic hepatitis B, the…
A simple shift in where new mothers receive care is helping the fight against hepatitis C. By bringing infectious…
The U.S. Food and Drug Administration (FDA) has given Lion TCR the green light to start Phase 1b/2 clinical…
Exposure to excessive alcohol disrupts the activity of a protein that plays a key role in keeping liver fat healthy,…
A gene-editing therapy designed to specifically inactivate a hidden genetic blueprint of the hepatitis B virus (HBV) — the cause…
One year of treatment with saroglitazar, Zydus Therapeutics’ experimental oral candidate, outperformed a placebo at normalizing markers of liver…